HolzerP: Opioids and opioid receptors in the enteric nervous system: From a problem in opioid analgesia to a possible new prokinetic therapy in humans. Neurosci Letters, 2004; 361:192–195.
2.
ChoiYS, BillingsJA: Opioid antagonists: A review of their role in palliative care, focusing on use in opioid-related constipation. J Pain Symptom Manage, 2002; 24:71–90.
3.
LataschL, ZimmermannM, EberhardtB, JurnaI: Treament of morphine-induced constipation with oral naloxone. Der Anaesthesist, 1997; 46:191–94.
4.
ThomasJ, KarverS, CooneyGA, et al.: Methylnaltrexone for opioid-induced constipation in advanced illness. N Engl J Med, 2008; 358:2332–2343.
5.
FordAC, BrennerDM, SchoenfeldPS: Efficacy of pharmacological therapies for the treatment of opioid-induced constipation: Systematic review and meta-analysis. Am J Gastroenterol, 2013; 108:1566–1574.
CheyWD, WebsterL, SostekM, et al.: Naloxegol for opioid-induced constipation in patients with noncancer pain. N Engl J Med, 2014; 370:2387–2396.
8.
CryerB, KatzS, VallejoR, et al.: A randomized study of lubiprostone for opioid-induced constipation in patients with chronic noncancer pain. Pain Med, 2014; 15:1825–1834.
9.
Mazen JamalM, MareyaSM, WoldegeorgisF, et al.: Lubiprostone significantly improves treatment response in non-methadone opioid-induced bowel dysfunction patients with chronic, non-cancer pain: Results from a phase 3, randomized, double-blind, placebo-controlled clinical trial. Gastroenterol, 2012; 142:S144–S145.
10.
BrennerDM, CheyDM: An evidence-based review of novel and emerging therapies for constipation in patients taking opioid analgesics. Am J Gastroenterol Suppl, 2014; 2:38–46.
